Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: Design of the MUSICA-2 randomized trial

American Heart Journal

Volumn 166, Issue 4, 2013, Pages 669-675

  Sambola, Antonia ^a   Montoro, J Bruno ^a   Del Blanco, Bruno García ^a   Llavero, Nadia ^a   Barrabés, José A ^a   Alfonso, Fernando ^b   Bueno, Héctor ^c   Cequier, Angel ^d   Serra, Antonio ^d   Zueco, Javier ^e   Sabaté, Manel ^e   Rodríguez Leor, Oriol ^f   García Dorado, David ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DRUG EFFICACY; DRUG SAFETY; EMBOLISM PREVENTION; FEMALE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART INFARCTION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SAMPLE SIZE; SINGLE BLIND PROCEDURE; STENT THROMBOSIS; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; STENTS; STROKE; SURVIVAL RATE; THROMBOEMBOLISM; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885174033     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.07.028     Document Type: Article

References (44)

1. V. Fuster, L.E. Rydén, and D.S. Cannom 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 15 123 2011 e269 e367
2. B.F. Gage, A.D. Waterman, and W. Shennon Validation of clinical classification schemes for predicting stroke results from the national registry of atrial fibrillation JAMA 282 2001 2864 2870
3. M. Leon, D. Baim, and J. Popma Randomized trial comparing three drug regimens to prevent thrombosis following elective coronary stenting N Engl J Med 339 1998 1665 1671
4. S.R. Mehta, S. Yusuf, and R.J. Peters Clopidogrel in unstable angina to prevent recurrent events trial (CURE) investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
5. G.N. Levine, E.R. Bates, and J.C. Blankenship 2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions Circulation 124 2011 e574 e651
6. W. Wijns, P. Kolh, and N. Danchin Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
7. J.L. Orford, P. Fasseas, and S. Melby Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation Am Heart J 147 2004 463 467
8. P.P. Karjalainen, P. Porela, and A. Ylitalo Safety and efficacy of combined antiplatelet warfarin therapy after coronary stenting Eur Heart J 28 2007 726 732
9. M. Nguyen, Y.L. Lim, and A. Walton Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J 28 2007 1717 1722
10. S. Manzano-Fernandez, F.J. Pastor, and F. Marin Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting Chest 134 3 2008 559 567
11. J.M. Ruiz-Nodar, F. Marín, and J.A. Hurtado Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation JACC 51 2008 818 825
12. A. Sambola, I. Ferreira-Gonzalez, and J. Angel Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study Heart 95 2009 1483 1488
13. M.L. Hansen, R. Sorensen, and M.T. Clausen Risk of bleeding with single, dual or triple therapy with warfarin, aspirin and clopidogrel in patients with atrial fibrillation Arch Intern Med 170 2010 1433 1441
14. F. Gao, Y.J. Zhou, and Z.J. Wang Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation Int J Cardiol 148 2011 96 101
15. J. Persson, J. Lindbäck, and C. Hofman-Bang Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome EuroIntervention 6 2011 1046 1052
16. M. Lamberts, J.B. Olesen, and M.H. Ruwald Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nation-wide cohort study Circulation 126 10 2012 1185 1193
17. E. Nikolsky, R. Mehran, and G.D. Dangas Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial) Am J Cardiol 109 6 2012 831 838
18. W. Chan, A.E. Ajani, and D.J. Clark Melbourne impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention. Interventional Group Investigators Am J Cardiol 109 2012 471 477
19. J.G. Smith, M. Wieloch, and S. Koul Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score EuroIntervention 8 2012 672 678
20. A.P. Annala, P.P. Karjalainen, and F. Biancari Long-term safety of drug-eluting stents in patients on warfarin treatment Ann Med 44 2012 271 278
21. J.G. Andrade, M.W. Deyell, and C. Khoo Risk of bleeding on triple antithrombotic therapy after percutaneous coronary intervention/stenting: a systematic review and meta-analysis Can J Cardiol 29 2 2013 204 212
22. G. Denas, S. Padayattil Jose, and P. Gresele Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study J Thromb Thrombolysis 35 2 2013 178 184
23. K.W. Ho, J. Ivanov, and X. Freixa Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation Can J Cardiol 29 2 2013 213 218
24. W.J. Dewilde, T. Oirbans, F.W. Verheugt for the WOEST study investigators Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Lancet 381 2013 1107 1115
25. A.J. Camm, P. Kirchhof, and G.Y. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery Eur Heart J 31 19 2010 2369 2429
26. S. Connolly, J. Pogue, R. Hart ACTIVE writing Group on behalf on the ACTIVE Investigators Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbersatan for prevention of vascular events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
27. D.P. Faxon, J.W. Eikelboom, and P.B. Berger Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary Circ Cardiovasc Interv 4 2011 522 534
28. S.V. Rao, K. O'Grady, and K.S. Pieper Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206
29. S.V. Manoukian, F. Feit, and R. Mehran Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial J Am Coll Cardiol 49 2007 1362 1368
30. R. Mehran, S.J. Pocock, and E. Nikolsky A risk score to predict bleeding in patients with acute coronary syndromes J Am Coll Cardiol 55 2010 2556 2566
31. J.W. Eikelboom, S.R. Mehta, and S.S. Anand Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 8 2006 774 782
32. B.J. Doyle, C.S. Rihal, and D.A. Gastineau Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice J Am Coll Cardiol 53 2009 2019 2027
33. R. Sørensen, M.L. Hansen, and S.Z. Abildstrom Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data Lancet 374 2009 1967 1974
34. J.S. Paikin, D.S. Wright, and M.A. Crowther Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents Circulation 121 18 2010 2067 2070
35. K.A. Fox Dual or single antiplatelet therapy with anticoagulation? Lancet 381 9872 2013 1080 1081
36. M.R. Patel, G.J. Dehmer, and J.W. Hirshfeld ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography Circulation 119 9 2009 1330 1352
37. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 31 20 2010 2501 2555
38. W.N. Whiteley, K.B. Slot, and P. Fernandes Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies Stroke 43 11 2012 2904 2909
39. K. Thygesen, J.S. Alpert, and A.S. Jaffe Third universal definition of myocardial infarction Circulation 126 16 2012 2020 2035
40. D.E. Cutlip, S. Windecker, and R. Mehran Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 17 2007 2344 2351
41. J.H. Chesebro, G. Knatterud, and R. Roberts Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation 76 1987 142 154
42. [No authors listed] Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators N Engl J Med 338 21 1998 1488 1497
43. E.L. Fosbol, T.Y. Wang, and S. Li Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction. Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction Am Heart J 163 4 2012 720 728
44. J.L. Anderson, J.L. Halperin, and N.M. Albert Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations): A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations): A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 127 18 2013 1916 1926